Meeder Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.2M Buy
84,741
+9,427
+13% +$1.09M 0.58% 44
2025
Q4
$7.93M Buy
75,314
+67,829
+906% +$6.37M 0.43% 53
2025
Q3
$628K Buy
7,485
+3
+0% +$247 0.04% 158
2025
Q2
$592K Buy
7,482
+96
+1% +$7.63K 0.04% 165
2025
Q1
$663K Sell
7,386
-210
-3% -$19.6K 0.04% 157
2024
Q4
$756K Sell
7,596
-54,690
-88% -$5.64M 0.05% 132
2024
Q3
$7.07M Sell
62,286
-188,509
-75% -$22.4M 0.47% 45
2024
Q2
$31M Buy
250,795
+240,201
+2,267% +$30.9M 2.18% 10
2024
Q1
$1.4M Buy
10,594
+3,583
+51% +$442K 0.09% 141
2023
Q4
$764K Sell
7,011
-1,100
-14% -$114K 0.06% 153
2023
Q3
$835K Sell
8,111
-75,823
-90% -$8.17M 0.07% 152
2023
Q2
$9.69M Sell
83,934
-4,865
-5% -$552K 0.7% 32
2023
Q1
$9.45M Buy
88,799
+1,633
+2% +$176K 0.75% 31
2022
Q4
$9.67M Sell
87,166
-47,192
-35% -$4.82M 0.85% 19
2022
Q3
$11.6M Buy
134,358
+1,298
+1% +$116K 0.67% 33
2022
Q2
$12.1M Buy
133,060
+4,961
+4% +$440K 0.7% 28
2022
Q1
$10.5M Buy
+128,099
New +$10.1M 0.51% 40
2021
Q4
Sell
-185,554
Closed -$13.9M 1888
2021
Q3
$13.9M Sell
185,554
-1,158
-0.6% -$88.1K 0.73% 26
2021
Q2
$14.5M Sell
186,712
-6,966
-4% -$518K 0.68% 29
2021
Q1
$14.2M Buy
193,678
+174,688
+920% +$12.9M 0.73% 26
2020
Q4
$1.48M Sell
18,990
-163,418
-90% -$12.5M 0.33% 58
2020
Q3
$14.4M Sell
182,408
-60
-0% -$4.7K 0.93% 16
2020
Q2
$13.5M Buy
182,468
+13,673
+8% +$1.03M 0.88% 17
2020
Q1
$12.4M Sell
168,795
-11,431
-6% -$898K 0.96% 14
2019
Q4
$15.6M Buy
180,226
+6,170
+4% +$507K 0.96% 15
2019
Q3
$14M Sell
174,056
-189
-0.1% -$15.1K 0.93% 15
2019
Q2
$13.9M Buy
174,245
+7,921
+5% +$607K 0.97% 18
2019
Q1
$13.2M Buy
166,324
+657
+0.4% +$49.1K 1.04% 15
2018
Q4
$12.1M Buy
165,667
+25,929
+19% +$1.83M 1.08% 14
2018
Q3
$9.46M Buy
139,738
+66,385
+91% +$4.23M 0.71% 32
2018
Q2
$4.25M Buy
73,353
+35,907
+96% +$2.03M 0.37% 79
2018
Q1
$1.95M Buy
37,446
+19,841
+113% +$1.07M 0.18% 128
2017
Q4
$946K Sell
17,605
-15,307
-47% -$849K 0.08% 240
2017
Q3
$2.01M Sell
32,912
-49,394
-60% -$2.99M 0.22% 122
2017
Q2
$5.03M Sell
82,306
-38,126
-32% -$2.32M 0.48% 49
2017
Q1
$7.3M Sell
120,432
-12,313
-9% -$747K 0.65% 33
2016
Q4
$7.46M Buy
132,745
+23,694
+22% +$1.39M 0.71% 27
2016
Q3
$6.49M Buy
109,051
+12,068
+12% +$706K 0.55% 29
2016
Q2
$5.33M Sell
96,983
-38,771
-29% -$2.06M 0.5% 32
2016
Q1
$6.85M Buy
135,754
+40,296
+42% +$1.97M 0.64% 31
2015
Q4
$4.81M Sell
95,458
-9,698
-9% -$489K 0.43% 47
2015
Q3
$4.96M Buy
105,156
+13,580
+15% +$721K 0.49% 45
2015
Q2
$4.97M Sell
91,576
-35,594
-28% -$2M 0.51% 35
2015
Q1
$6.97M Buy
127,170
+10,999
+9% +$623K 0.75% 24
2014
Q4
$6.29M Sell
116,171
-41,490
-26% -$2.31M 0.8% 30
2014
Q3
$8.92M Buy
+157,661
New +$8.85M 1.31% 8

Other funds holding MRK

Meeder Asset Management's MRK Position: Q1 2026 in Review

Meeder Asset Management increased its Merck (MRK) stake by 13% in Q1 2026, buying an estimated $1.09M and bringing the position to 84,741 shares worth $10.2M. The position accounts for 0.58% of the portfolio, ranked #44.

Meeder Asset Management first reported a position in MRK in Q3 2014 and has held it in 46 quarters since. The position peaked at $31M in Q2 2024. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Meeder Asset Management held 84,741 shares of Merck worth $10.2M as of Q1 2026.
  • Meeder Asset Management bought 9,427 Merck shares in Q1 2026, an estimated $1.09M.
  • Merck made up 0.58% of Meeder Asset Management's portfolio in Q1 2026, its #44 holding.
  • Meeder Asset Management first reported a position in Merck in Q3 2014 and has held it in 46 quarters since.
  • Meeder Asset Management's Merck position peaked at $31M in Q2 2024.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Meeder Asset Management's 13F filing for Q1 2026, filed 7 May 2026.